Member Info for Toyin

Aguae, I understand what your saying but the website is run by a third party and we don’t know how it is set up.

Let’s look at this from a different angle, If you were the nomad what sales figure would you want to see from the board in feb to ok the £1.2m forecast? Bearing in mind it is your duty to protect shareholders.

No problem Cliostock.

On Feb 17 when the £1.2m was put out we had circa 500 orders showing in the UK. (I know this because I made a purchase on the 15th, I made a purchase on day one and we started at order no 1000 or thereabouts.) Now if you say each order was the maximum value £52.50 that equates to £26,250 (I have not took in to consideration the US or the bogof offer)

There is no way, and I mean no way the nomad or Stuart would put out a forecast of hitting £1.2m by June end if we had £26k in sales at Feb 17th, even if we said the US had done the same and we doubled that figure to £52k, the nomad would need concrete evidence that the £1.2m was achievable at that point (feb 17th), £52k just wouldn’t cut it. You have sold £52k in four and a half months and you think you will do £1.15m in the remaining four and a half months?

I agree with your point that order no’s are relevant for a business and I don’t know why they are doing it, but I am absolutely positive they are. The order numbers are a red herring, I am sure of that.

Please feel free to rip my theory apart, criticism welcomed.

I believe the order numbers are irrelevant, do the maths.

Dire, nobody needs to nudge anyone out the way, there is plenty of room at the table. Do the maths.

nick.

Mr Ashman said it in his interview with Elric for starters, I suggest you watch it. Just because it’s not in an rns doesn’t mean it’s not a fact, you are more than welcome to ignore those facts and stick to rns’s.

rebarm, no problem.

First of all, I never said “no budget” I said he doesn’t have the budget, meaning he is spending what he has on what he thinks is the right place.

Second of all, Stuart has, on several occasions, after the £1.2m miss said, sales are increasing on a daily basis and the retention rate is circa 70%, this is a fact. Now I don’t know if you class this as “published data” but it is a fact.

Let’s deal with these two points first so we don’t get lost!

rebarm, I find this board to be very balanced, the problem is this rampers narrative will never get you anywhere unless of course you are just trying to cause trouble. If you are bullish, you are a ramper, whatever!

Now to business, the launch of axisbiotix was not a damp squib, we had a soft launch and then a full launch, sales are growing everyday and the retention rate is circa 70%. These are facts.

AxisBiotix is not being pumped all over the media because Stuart, (a) doesn’t have the budget, (b) it wouldn’t be a very constructive use of money anyway as Stuart has pointed out, he wants as much bang for his buck as possible.

AxisBiotix, as far as I am concerned still is the big story at the moment, because that’s what I have the most information on. Regarding Croda, I have seen and read the presentations. The lysate is still with vip client’s for testing, why would Croda mention it yet, “hey guys we have this exciting lysate but it’s in the testing phase so can’t really say anything”

Oleric, I for one will answer any question anyone asks if I have something worthwhile to add.

For the record from a ramper. I was extremely disappointed when the £1.2m was missed and I agree Stuart dropped the ball, it was a blow. The problem is certain posters then wanted his head on a plate, well that was just ridiculous, Stuart has made one mistake up to now, with all he has achieved I think that’s an exceptional hit rate.

Thank you Aquae, yes it’s certainly a win win for me. I’m sure Elric will get an answer for you.

Firstly Aquae, I agree 100% with you, not all rules and regulations are sensible, unfortunately they are what they are. I would guess the website and the packaging will fall under the same rules but again I am no expert and it may be worth dropping the company an email to clarify.

On the different blends point, I think Stuart has got a monster on his hands here, and I agree lots of different products will come from this base blend, for eg. My daughter has suffered from gastroparesis for about 5 years, she’s been to the hospital for the camera etc, under a consultant at the spire to no avail. The only thing they could do was put her on omeprazole to stop the reflux but you need the acid to digest the food, so no win there. Symptoms, tummy pains, bloating, acid reflux, halitosis, plus just generally feeling rubbish as she has undigested food in her stomach all the time. I got her to start taking my axisbiotix, 1 week later all symptoms gone and I mean gone. Upside she feels great, downside it’s costing me another £30 a month!

Aquae, nobody agrees with you more than me. But until it is a “fact” proven under the right conditions we cannot change the wording. If you want a proper answer, contact axisbiotix on the website they will give you the official line.

Aquae, you have just removed the three words that would absolutely drop us in the ****.

Aquae, I think I understand what you are saying. The difference is when the company issues an rns they aren’t advertising/selling a product to the public, the website is there solely to sell a product. That is why the wording has to be different, there are no advertising rules for rns’s, there is for online shop windows.

https://www.gov.uk/food-labelling-and-packaging/nutrition-health-claims-and-supplement-labelling

Oleric, TW's last update after the sales miss rns was probably his most bullish yet, he also bought more.

Regarding the study being full of holes, thats a very sweeping statement with no evidence to back it up. On the flip side, the study suggested circa 70% of cohorts saw positive results, the real world retention is circa 70% and the initial review's coming through on Trustpilot are 81% of customers rate it excellent, which are all in the same ballpark. Regarding your "nobody has heard of the product" again this is a silly statement because sales are growing on a daily basis.

I think it would be wise to deal with facts rather than emotional ramblings just because you have crystallised a loss. You think it is more of a gamble, you may well be right, but again let's ask a fact based question, after testing our product would Croda spend €5m on a production facility specifically for our lysate?

Aquae, legally they aren't allowed to make specific claims because it is sold as a food supplement. They have pointed it towards Psoriasis sufferers as best they can within the rules. To make specific claims would mean trials etc and would take a lot of money and time.

lord, the £22k was a soft launch, it was nothing to do with sales generation, the clue is in the "soft launch" bit, it was checking supply chain issues etc, hence why Stuart has said sales now look nothing like Nov/Dec. For the record Lewis Hamilton is bang average were as Stuart is top draw.

Phat, I think you will find lord is Mr O'Hara in disguise, the cheeky monkey is trying to get investors to swop allegiance. lol.

Opti wont have much of a stake left if Mr O'Hara keeps dumping!

lord, opti sales were £2.2m for the whole group before they spun the probiotic division off and that's after 5 years of trying, Stuart's had 5 months! If you think sbtx is overvalued, I think you need re-crunch your opti info! And as Phat rightly points out, we have lots more going on!

On reflection, I think I can be bothered.

I have the utmost faith in Stuart, he has taken our first product and got it on sale generating revenues within 12 months from a standing start with a business that was set up solely as a b2b, he has now added a b2c element to the company which will also bear much fruit when we launch other products, acne etc. So let’s recap, formulated, study completed, data published, soft launch concluded, full launch, influencer program, (apologies if I missed any stages) he did all this whilst also dealing with Croda, oral, and acne, plus any other discussions/negotiations in other pillars, and you think he should be sacked!

It wasn’t beer and curry, it was just drinks, I had a lime and soda.

Very poor taste but I will debunk your theory, Stuart is not on a mid six figure salary, that figure includes options (which are linked to performance), pension etc. I would also like to say Stuart took a pay cut to join the company.

Ok, now I have blown smoke up his arse, let’s look at what he got wrong:

He agreed to a forecast issued by Cenkos that both the board and the nomad thought was achievable and he has missed it, for now. It’s a when not an if. Is this a sackable offence, I think not, personally if he asked for a raise I would give it him.

Advice, better to keep quiet and let people think you are stupid than open your mouth and prove them right.

Have a nice weekend.

Ody, can I just say, you have wasted 10 minutes of your life, you say:

“1.2 million target actually achieving £21k.... jesus.... that IS MATERIAL. Good grief. So the company achieved under 2% (about 1.79%) of its sales target.....”

The £21k is for sales up to the end of December 2021, the £1.2m was the target for sales up to the end of June 2022 (so we will have another 6 months of sales to add to the £21k). I could go on, but the fact that your main point is so banal and fundamentally flawed I can’t be bothered.